DACH unquote
Constellation acquires Rehms
Family-owned business turns to PE for succession planning
Kizoo leads Shyftplan series-A round
Company will merge its Pijajo and Shyftplan products as part of the deal
Neuhaus Partners et al. reinvest in Searchmetrics
Most recent round of funding adds to €8.5m raised since 2010
BayBG backs Miflora
Miflora previously received investment from Atlantic Capital Partners et al.
HTGF injects €500,000 into Lockbox
Delivery system company set to expand across Germany
HPE acquires 13% stake in Kreditech
Värde led $40m series-B round for the company in June
Germany: Some boom amid the doom and gloom
Macroeconomic pressures are being felt in the local PE market, but there are some bright spots emerging
Kion to list further 8 million shares
KKR and Goldman Sachs divest further stake in 2007-vintage portfolio company
Deutsche Telekom establishes new fund
T-Venture is now closed to new investments
Parter Capital injects CHF 4.5m into Histide
Private equity house specialises in research-based investments
Montana closes second fund on $100m
Montana Annual Secondary Program II closes on hard-cap after three months
Seventure et al. back Humedics’ series-C
Company's existing investors also committed to the round
BayBG backs Eyeglass24
Online lens seller reaps more than €1m in second funding round this year
Halder acquires Amoena Group in SBO
Baird divests portfolio company after almost eight years
Venture capital backs Electrochaea
Series-A funding round sees company relocate from Chicago to Munich
EQT buys Siemens Audiology Solutions for €2.15bn
Private equity group intends to list the company
Molecular floats with CHF 482m market cap
Shares dropped to CHF 22.4 within hours, having opened on CHF 25
Bayer commits $25m to Versant's fifth fund
Bayer and Versant had already worked together on drug discovery incubator
Molecular Partners to raise CHF 96m after IPO delay
Offering will give company a market cap of CHF 485m
Wellington et al. divest Definiens in $150m trade sale
Gilde Healthcare, TVM Capital and Cipio Partners also exit company
Venture-backed F-Star acquired by Bristol-Myers Squibb
Bristol has acquired Viennese company F-Star Alpha for up to $475m
Probiodrug raises €22.5m in Euronext IPO
Fresh capital to be used for advancing development of Alzheimer's drug
MYR receives €7.9m from HTGF et al.
MYR and Russian company Hepatera working on joint drug project
DPE acquires Ziegler Group
Two firms work together on growth plan to 2020